Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.75
-0.55 (-4.14%)
Mar 9, 2026, 1:30 PM CST
-37.80%
Market Cap 1.51B
Revenue (ttm) 482.03M
Net Income (ttm) 3.26M
Shares Out 118.74M
EPS (ttm) 0.03
PE Ratio 465.10
Forward PE n/a
Dividend 0.50 (3.76%)
Ex-Dividend Date Sep 24, 2025
Volume 424,757
Average Volume 224,626
Open 13.25
Previous Close 13.30
Day's Range 12.15 - 13.25
52-Week Range 12.65 - 21.35
Beta -0.01
RSI 25.14
Earnings Date Mar 27, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa... [Read more]

Industry Packaged Foods
Founded 1995
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4109
Full Company Profile

Financial Performance

In 2024, Jia Jie Biomedical's revenue was 537.07 million, an increase of 61.40% compared to the previous year's 332.76 million. Earnings were 211.37 million, an increase of 46.64%.

Financial Statements

News

There is no news available yet.